Results Enter location to sort by distance. Trial Research Area Duration Locations A5407: Placebo-controlled Phase 3 Outpatient Trial of Shionogi Agent for Treatment of Symptomatic SARS-CoV-2 Infection Open and enrolling COVID-19 See locations